Kaneko T, Willner D, Monkovíc I, Knipe J O, Braslawsky G R, Greenfield R S, Vyas D M
Bristol-Myers Squibb Company, Wallingford, Connecticut 06492-7660.
Bioconjug Chem. 1991 May-Jun;2(3):133-41. doi: 10.1021/bc00009a001.
New N-substituted hydrazine linkers were synthesized and their hydrazone derivatives of adriamycin were prepared. These functionalized adriamycin derivatives were conjugated with a monoclonal antibody, 5E9. The release rate of adriamycin from the hydrazones and from some of the conjugates was studied, and their relationship to the IC50's of the conjugate against 5E9-positive Daudi cells was investigated.
合成了新型N-取代肼连接体,并制备了其阿霉素腙衍生物。这些功能化的阿霉素衍生物与单克隆抗体5E9偶联。研究了阿霉素从腙以及一些偶联物中的释放速率,并研究了它们与偶联物对5E9阳性Daudi细胞的IC50值之间的关系。